XML 21 R6.htm IDEA: XBRL DOCUMENT v3.19.3
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net Income (Loss) $ (115,050) $ 688,227
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Gain on Disposition of Operating Partnerships (47,500) (841,020)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 2,000 (2,000)
(Decrease) Increase in accounts payable affiliates (1,144) (1,040,288)
Net cash provided by (used in) operating activities (161,694) (1,195,081)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 47,500 841,020
Net cash provided by investing activities 47,500 841,020
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (114,194) (354,061)
Cash and cash equivalents, beginning 1,055,755 1,632,938
Cash and cash equivalents, ending 941,561 1,278,877
Series 15    
Cash flows from operating activities:    
Net Income (Loss) 0 (35,236)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Gain on Disposition of Operating Partnerships 0 (12,500)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 0 0
(Decrease) Increase in accounts payable affiliates 0 (43,126)
Net cash provided by (used in) operating activities 0 (90,862)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 12,500
Net cash provided by investing activities 0 12,500
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 0 (78,362)
Cash and cash equivalents, beginning 0 244,074
Cash and cash equivalents, ending 0 165,712
Series 16    
Cash flows from operating activities:    
Net Income (Loss) (21,267) (65,997)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Gain on Disposition of Operating Partnerships (47,500) 0
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 4,500 (2,000)
(Decrease) Increase in accounts payable affiliates (33,040) (115,641)
Net cash provided by (used in) operating activities (97,307) (183,638)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 47,500 0
Net cash provided by investing activities 47,500 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (49,807) (183,638)
Cash and cash equivalents, beginning 191,974 320,396
Cash and cash equivalents, ending 142,167 136,758
Series 17    
Cash flows from operating activities:    
Net Income (Loss) (44,966) 53,830
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Gain on Disposition of Operating Partnerships 0 0
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses (2,500) 0
(Decrease) Increase in accounts payable affiliates 0 0
Net cash provided by (used in) operating activities (47,466) 53,830
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 0
Net cash provided by investing activities 0 0
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (47,466) 53,830
Cash and cash equivalents, beginning 607,576 536,326
Cash and cash equivalents, ending 560,110 590,156
Series 18    
Cash flows from operating activities:    
Net Income (Loss) (48,817) 755,608
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Gain on Disposition of Operating Partnerships 0 (815,520)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 0 0
(Decrease) Increase in accounts payable affiliates 31,896 (881,521)
Net cash provided by (used in) operating activities (16,921) (941,433)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 815,520
Net cash provided by investing activities 0 815,520
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS (16,921) (125,913)
Cash and cash equivalents, beginning 256,205 351,136
Cash and cash equivalents, ending 239,284 225,223
Series 19    
Cash flows from operating activities:    
Net Income (Loss) 0 (19,978)
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities    
Gain on Disposition of Operating Partnerships 0 (13,000)
Changes in assets and liabilities    
(Decrease) Increase in accounts payable and accrued expenses 0 0
(Decrease) Increase in accounts payable affiliates 0 0
Net cash provided by (used in) operating activities 0 (32,978)
Cash flows from investing activities:    
Proceeds from the disposition of Operating Partnerships 0 13,000
Net cash provided by investing activities 0 13,000
INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS 0 (19,978)
Cash and cash equivalents, beginning 0 181,006
Cash and cash equivalents, ending $ 0 $ 161,028